How Does Veozah (Fezolinetant) Actually Work?

What is Veozah actually approved to treat?

Veozah earned FDA approval in May 2023 for a single, narrow indication: moderate-to-severe vasomotor symptoms — the clinical name for hot flashes and night sweats — caused by menopause. That's the entire label. It isn't approved for perimenopausal mood changes, sleep problems on their own, vaginal dryness, bone loss, or weight, even though all of those show up in the same stretch of life for a lot of women. If hot flashes and night sweats are your main complaint, you're squarely in the population this drug was actually built and tested for.

If you've come across Ozempic, Wegovy, or other GLP-1 explainers while researching midlife health, it's worth being clear: Veozah has nothing to do with that drug class. It doesn't touch appetite, blood sugar, or GLP-1 receptors at all — it's a completely different molecule, treating a completely different symptom.

What's actually happening in your body when you take it?

To understand what Veozah does, it helps to know what's causing the hot flash in the first place. Deep in the hypothalamus — the part of the brain that regulates body temperature — sits a cluster of neurons researchers call KNDy neurons, named for the three signaling chemicals they produce: kisspeptin, neurokinin B, and dynorphin. During your reproductive years, estrogen keeps these neurons in check. As estrogen declines through perimenopause and into menopause, that brake loosens, and neurokinin B signaling runs largely unopposed.

That unchecked signaling overstimulates the KNDy neurons, and their activity spills over onto the brain's nearby thermoregulatory center. The brain misreads the surge as a sign the body is overheating and triggers the response you actually feel — blood vessels near the skin widen, you sweat, your heart rate ticks up. That's a hot flash. Fezolinetant works by selectively blocking the NK3 receptor that neurokinin B binds to on those neurons, quieting the signal before it reaches the temperature-control center. It doesn't add estrogen back, and it doesn't touch the ovaries or any hormone-producing tissue at all — it interrupts one specific brain signal instead.

How do you actually take the 45mg tablet?

There's no titration schedule with Veozah — no working up to the real dose over a few weeks the way some prescriptions require. You start at the full 45mg tablet, taken once a day, and that's the only dose it comes in. It can be taken with or without food; there's no fasting window and no timing rule tied to meals. What does matter is taking it around the same time each day, since that steady rhythm is what keeps blood levels consistent, rather than dosing whenever it happens to come to mind.

Does Veozah come in a patch, cream, or anything besides this tablet?

No. As of 2026, fezolinetant exists in exactly one form on the market: this 45mg oral tablet, manufactured only by Astellas Pharma. There's no Veozah patch, no cream, no injectable version, and no compounded fezolinetant sold through a compounding pharmacy the way you'll sometimes find with bioidentical hormones. That last point is worth being specific about: fezolinetant is a patent-protected, single-source synthetic molecule, not a hormone a 503A pharmacy can legally recreate from raw ingredients.

There's also no generic version yet — fezolinetant's patent runs to roughly 2034, which is part of why the tablet's cash price stays high with nothing to shop it against. If you come across a menopause product marketed anywhere as a 'fezolinetant patch' or 'fezolinetant cream,' that isn't a real, FDA-recognized product — treat it as a red flag rather than a shortcut.

Is Veozah a hormone? How is it different from HRT?

No — Veozah contains no estrogen, no progesterone, and no hormone of any kind. That's the entire point of its mechanism: it works downstream of estrogen decline, on the brain signal that decline sets off, rather than replacing the hormone itself. Hormone therapy takes the opposite approach, restoring the estrogen your ovaries have largely stopped making, which is also why HRT's reach extends further — to bone density, vaginal tissue, and sleep — in ways a hot-flash-specific drug like Veozah isn't built or approved to touch.

That narrower scope isn't a flaw; it's exactly why Veozah exists as an option. It gives women who can't or don't want to use hormones — because of a personal history of certain cancers, a clotting risk, or simple preference — an FDA-approved, evidence-backed way to treat hot flashes specifically. For the deeper side-by-side on efficacy, safety, and cost, see Veozah vs. estradiol; for what hormone therapy itself actually involves at this life stage, see hormone therapy in perimenopause.

How soon will you feel it working?

Some women notice a difference within the first week, based on daily symptom tracking in Veozah's SKYLIGHT trials, though the benefit doesn't become statistically distinguishable from placebo until around week 4, and keeps building through week 12. That's the short version — for the full week-by-week breakdown of what to actually expect, and how to tell real progress from just a good week, see how long Veozah takes to work.

Who is Veozah for, and who shouldn't take it?

The clearest candidates are women with moderate-to-severe hot flashes and night sweats who can't or don't want to use hormone therapy — a history of estrogen-sensitive breast cancer, a personal or family history of blood clots, a bad experience with HRT, or simply a preference to avoid hormones altogether. Normal baseline liver function is the other real prerequisite, and it isn't a formality.

On December 16, 2024, the FDA added a boxed warning — its most serious labeling action — to Veozah, after a postmarketing case of serious liver injury that resolved once the patient stopped taking the drug. Because of that, Veozah is contraindicated outright in anyone with cirrhosis, including its mildest classification, Child-Pugh Class A, and in anyone taking a strong CYP1A2 inhibitor such as fluvoxamine, which raised fezolinetant exposure in trial data several-fold.

Prescribers now check liver function tests before you start. Follow-up tests happen at months 1, 2, 3, 6, and 9 of treatment, with instructions to stop the drug right away if enzyme levels climb too high.

• Fatigue that doesn't track with anything else going on
• Yellowing of the skin or eyes (jaundice)
• Dark or tea-colored urine
• Pale or clay-colored stools
• Unusual, unexplained abdominal pain

Any of those, and the guidance is the same: stop the tablet and call whoever prescribed it the same day, rather than waiting to see if it passes.

What if you miss a dose, or decide to stop taking it?

If you miss your usual time, take it as soon as you remember — unless fewer than 12 hours remain before your next scheduled dose, in which case you skip the missed one and just resume your normal schedule. Never double up to make up for a missed pill. One occasional miss won't undo weeks of progress, since the benefit reflects an ongoing effect rather than a single dose sitting in your system.

Stopping is more straightforward than it is with some hormone regimens. Because Veozah doesn't suppress or replace anything your body makes on its own, there's no tapering schedule described in its prescribing information — you can stop on your prescriber's guidance without weaning off a dose. What happens afterward is less certain: the drug treats the hot flash signal itself rather than reversing the estrogen decline underneath it, so hot flashes are likely to return on their own timeline once you stop, though there isn't published data describing exactly how that unfolds for most women.

What does Veozah cost, and how do you actually get it?

Veozah is prescription-only — an OB/GYN, primary care provider, or a menopause-focused telehealth platform can write it after reviewing your liver function and full medication list. What you'll actually pay swings widely depending on insurance, a manufacturer copay card, and where you fill it, which is exactly the kind of variation a single number on this page couldn't do justice to.